Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia: San Diego Monday, January 13, 2025, 16:30 Hrs [IST] Crinetics Pharmac ...

The following is a summary of “Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors,” published in the January 2025 issue of ...